Stockholders’ Equity (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Feb. 08, 2022 |
Mar. 31, 2023 |
Mar. 31, 2022 |
|
| Class of Stock [Line Items] | |||
| Research and development expense | $ 3,970 | $ 4,978 | |
| Number of warrant to purchase of common stock | 238,000 | ||
| Class of warrant or right, exercise price | $ 0.75 | ||
| Warrant expiration | Jun. 21, 2023 | ||
| Restated Exclusive License Agreement [Member] | |||
| Class of Stock [Line Items] | |||
| Milestone fee | $ 100 | ||
| License fee | 50 | ||
| Research and development expense | $ 291 | ||
| Stock issued during new issued, shares | 400,000 | ||
| Share price | $ 0.728 | ||
| Restated Exclusive License Agreement [Member] | Unregistered Shares [Member] | Rutgers [Member] | |||
| Class of Stock [Line Items] | |||
| Business acquisition, equity iterest issued or issuable, shares | 400,000 | ||
| X | ||||||||||
- Definition License fee. No definition available.
|
| X | ||||||||||
- Definition Milestone fee. No definition available.
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|